Q BioMed Inc. (QBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 22, 2025, 4:00 PM EDT
Q BioMed Balance Sheet
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2014 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '23 Feb 28, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | Nov '18 Nov 30, 2018 | 2014 - 2017 |
| Cash & Equivalents | 0.02 | 0.05 | 0.34 | 0.18 | 0.17 | 2.68 | Upgrade
|
| Cash & Short-Term Investments | 0.02 | 0.05 | 0.34 | 0.18 | 0.17 | 2.68 | Upgrade
|
| Cash Growth | -83.11% | -85.47% | 94.20% | 2.61% | -93.57% | 225.47% | Upgrade
|
| Receivables | - | 0.01 | 0.08 | - | - | - | Upgrade
|
| Inventory | - | - | 0.02 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.01 | 0.01 | 0.01 | 0.05 | 0.02 | 0.01 | Upgrade
|
| Total Current Assets | 0.03 | 0.07 | 0.46 | 0.22 | 0.19 | 2.7 | Upgrade
|
| Long-Term Investments | 3.14 | 3.14 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 0.29 | 0.3 | 0.35 | 0.4 | 0.45 | 0.5 | Upgrade
|
| Total Assets | 3.46 | 3.52 | 0.81 | 0.62 | 0.64 | 3.2 | Upgrade
|
| Accounts Payable | 2.25 | 2.13 | 1.35 | 0.72 | 0.65 | 0.17 | Upgrade
|
| Accrued Expenses | 3.48 | 1.8 | 1.1 | 0.89 | 1.34 | 0.26 | Upgrade
|
| Short-Term Debt | 4.08 | 4.11 | 3.05 | 0.09 | 0.5 | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0 | 2.74 | - | Upgrade
|
| Other Current Liabilities | 0.09 | 0.09 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 9.91 | 8.13 | 5.49 | 1.7 | 5.24 | 0.43 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.45 | 2.87 | Upgrade
|
| Other Long-Term Liabilities | - | -0 | - | - | - | - | Upgrade
|
| Total Liabilities | 9.91 | 8.13 | 5.49 | 1.7 | 5.69 | 3.3 | Upgrade
|
| Common Stock | 0.13 | 0.08 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 56.55 | 56.31 | 53.34 | 47.66 | 37.33 | 31.99 | Upgrade
|
| Retained Earnings | -68.32 | -66.1 | -64.13 | -55.89 | -42.39 | -32.11 | Upgrade
|
| Total Common Equity | -11.63 | -9.7 | -10.76 | -8.21 | -5.05 | -0.11 | Upgrade
|
| Shareholders' Equity | -6.44 | -4.62 | -4.69 | -1.08 | -5.05 | -0.11 | Upgrade
|
| Total Liabilities & Equity | 3.46 | 3.52 | 0.81 | 0.62 | 0.64 | 3.2 | Upgrade
|
| Total Debt | 4.08 | 4.11 | 3.05 | 0.09 | 3.69 | 2.87 | Upgrade
|
| Net Cash (Debt) | -4.06 | -4.06 | -2.71 | 0.08 | -3.52 | -0.19 | Upgrade
|
| Net Cash Per Share | -0.06 | -0.09 | -0.10 | 0.00 | -0.23 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 145.09 | 144.09 | 30.6 | 25.86 | 20.84 | 14.47 | Upgrade
|
| Total Common Shares Outstanding | 133.03 | 84.33 | 28.65 | 23.82 | 19.71 | 14.29 | Upgrade
|
| Working Capital | -9.87 | -8.06 | -5.04 | -1.48 | -5.05 | 2.27 | Upgrade
|
| Book Value Per Share | -0.09 | -0.12 | -0.38 | -0.34 | -0.26 | -0.01 | Upgrade
|
| Tangible Book Value | -11.92 | -10 | -11.11 | -8.61 | -5.5 | -0.61 | Upgrade
|
| Tangible Book Value Per Share | -0.09 | -0.12 | -0.39 | -0.36 | -0.28 | -0.04 | Upgrade
|
Updated Jun 16, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.